Formosa Pharmaceuticals, Inc. (TPE:6838)
Taiwan
· Delayed Price · Currency is TWD 25.60
-1.40 (-5.19%)
At close: Mar 9, 2026
Formosa Pharmaceuticals Market Cap
Formosa Pharmaceuticals has a market cap or net worth of 3.87 billion as of March 9, 2026. Its market cap has decreased by -26.54% in one year.
Market Cap
3.87B
Enterprise Value
2.38B
Revenue
12.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.60
Market Cap Chart
Since October 7, 2021, Formosa Pharmaceuticals's market cap has decreased from 5.53B to 3.87B, a decrease of -30.17%. That is a compound annual growth rate of -7.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 4.08B | 2.27% |
| Dec 31, 2025 | 3.99B | -29.51% |
| Dec 31, 2024 | 5.65B | -15.62% |
| Dec 29, 2023 | 6.70B | 13.17% |
| Dec 30, 2022 | 5.92B | 74.66% |
| Dec 30, 2021 | 3.39B | -38.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Energenesis Biomedical CO.,LTD. | 4.18B |
| Medigen Biotechnology | 4.20B |
| Genovate Biotechnology | 3.94B |
| ACRO Biomedical | 3.75B |
| BioGend Therapeutics | 4.53B |
| Senhwa Biosciences | 4.62B |
| Sagittarius Life Science | 3.51B |
| BRIM Biotechnology | 3.44B |